| Filed On | Filing |
|---|---|
| 21 Oct 2026 | 13F-HR |
| 21 Oct 2026 | N-30B-2 |
| 30 Jul 2026 | N-CSRS |
| 29 Jul 2026 | NPORT-P |
| 29 Jul 2026 | N-PX |
| 22 Jul 2026 | 13F-HR |
| 30 Apr 2026 | NPORT-P |
| 22 Apr 2026 | N-30B-2 |
| 22 Apr 2026 | 13F-HR |
| 14 Apr 2026 | 40-17G |
| 30 Mar 2026 | SCHEDULE 13D/A |
| 11 Mar 2026 | N-CEN |
| 25 Feb 2026 | NPORT-P |
| 20 Feb 2026 |
Form 3: Chambers Steven G, Director
Holds 3,845 shares of Common Stock |
| 20 Feb 2026 | N-CSR |
| 18 Feb 2026 | Proxy statement: annual meeting on April 16, 2026 |
| 13 Feb 2026 | 13F-HR |
| 12 Feb 2026 |
Form 5: Dale Kenneth James, Director
Received 771.1475 shares as a grant or award · Acquired 487 shares (Other Transaction) |
| 06 Feb 2026 |
Form 5: Stoeckle Mark E., Director
Acquired 246.243 shares (Other Transaction) |
| 06 Feb 2026 |
Form 5: Nelson Jane Musser, Director
Acquired 261 shares (Other Transaction) |
Loading...
